Healthcare and life sciences occupy more the 18% of the U.S. economy and are a core area of entrepreneurialism and investment. New Mexico has an important history of innovation in the healthcare and life sciences industries, including one of the largest university technology transfer wins ever – the nicotine patch invented at New Mexico Tech in the late 1970s. With the intellectual engines of the national lab system and our research universities, there are many opportunities in this industry for both innovators and investors.
However, understanding how to find and commercialize on these opportunities is challenging as information is non-centralized, uncoordinated, and not especially visible. So come and join CVF as we shed light on this under-represented part of the entrepreneurial ecosystem in the State. We are honored to feature Stuart Rose, Founder of The BioScience Center in Albuquerque, for a keynote address, then we will open things up for a dynamic panel discussion including leaders of New Mexican healthcare and life sciences companies. Each of our panelists will be asked to explore the opportunities and challenges of the industry and operating within the New Mexican ecosystem. Audience participation will be encouraged through an interactive question and answer session.
Founder of The BioScience Center
Stuart Rose is a Ph.D. Chemist by training and an evangelist for entrepreneur-ism at heart. Even in the corporate world, where he held numerous executive positions in the pharmaceutical industry, he was always a maverick. Stu has lived and worked outside the USA (from Puerto Rico to Moscow) and built companies throughout Europe and Asia, including in China and India. After departing big Pharma, he became involved in a number of turnarounds and startups. In 2008, he purchased a failing Albuquerque company, rebranded and turned it around as Oso Biopharmaceuticals Manufacturing and handed it over to the next generation of management, all within 3 1/2 years. Last year, he purchased a vacant Albuquerque building and created the highly successful BioScience Center, New Mexico’s first privately-funded, for profit business incubator. He will talk about how he thinks NM can turn around its economy by becoming a haven for startups and small businesses.
Owner, Upham BioConsulting
Upham BioConsulting provides strategic, marketing, and financial services to start up biotechnology companies. Loraine is a co-inventor of a novel diabetes treatment and a co-founder of CureDM, the company that licensed the drug in a $335M deal with Sanofi-Aventis in 2010. As founding CEO of CureDM, she successfully obtained start up financing and engineered partnerships to conduct basic research and establish the proof of concept. Her 28 year career in the Pharmaceutical and Biotechnology Industries include four years of cloning and expression research in the Molecular Genetics Research Department at Eli Lilly and Company. Subsequent to Lilly, Lori joined Merck and Co. and then ventured into the realm of smaller companies both in the device and biotechnology areas, including a decade in nuclear and fluorescence detection instrumentation and assay development at Packard BioScience (now Perkin Elmer), and two years in process and business development at Prolexys Pharmaceuticals. Lori holds a BA in Biology from the University of Pennsylvania and an MBA from Arizona State University.
President and CEO, Respira Therapeutics
Bob has 35+ years of medical technology company operating experience, with 25+ years at the CEO level, having raised and invested $195+ million in VC and corporate transactions and served as CEO of eleven medical technology-driven start-ups in multiple specialty markets ranging from seed-stage venture backed start-ups to turnarounds. Eight of these companies had subsequent liquidity events for investors. Before Respira, Bob served as President and CEO of MyoScience. Prior to MyoScience, Bob served as Principal of Robert Curtis Associates and as CEO of Medtech Ventures, a VC incubator. Bob has also served as CEO of multiple medical technology firms: Avasca Medical, CardiacMD/AorTx, HemoSense, Artemis Medical, Norborn/Revascular Therapeutics, Eunoe, Urosystems, Autogenics/Arbor Surgical, and Aerogen. Bob holds a B.S. in Chemical Engineering and an M.S. in Mechanical/Bioengineering from UC Berkeley. He is the inventor of multiple successful medical device products and holds eleven U.S. and foreign patents.
CFO, Exagen Diagnostics
Wendy Swedick is CFO for Exagen Diagnostics. Wendy has over 20 years of executive finance experience providing leadership in both corporate and entrepreneurial organizations. She was part of the senior management team at Media One Group, a $3 billion telecommunications company, which was successfully sold to AT&T for $44 billion. Wendy is currently a senior mentor for the New Directions Institute and graduated with honors with a B.A. in Business Administration & Accounting from the University of New Mexico and the Leadership New Mexico program.
VP of Finance & Operations , xF Technologies
xF Technologies is a biofuels start up based in Albuquerque. Matt joined xF Technologies from Sun Mountain Capital, a venture capital firm. At Sun Mountain, Matt was a Principal who’s responsibilities included investment sourcing and management as well as valuations and reporting. Prior to Sun Mountain, Matt worked for Bank of America’s investment banking business. At BofA, Matt was an Analyst in the Private Equity Placements Group and part of a team responsible for deal sourcing and execution. Matt has a BBA in Finance from the University of Texas at Austin.
Date: Thursday, January 16, 2014
Time: 6-8 pm
Venue: Prairie Star Restaurant
288 Prairie Star Rd.
Bernalillo, NM 87004
Cost: $22.50 in advance (credit card payments); $25 at the door (cash and check only).